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Abstract: The objective of this work was to evaluate the physical properties and in vivo 
circulation of chitosan (CH)-coated liposomes of mitoxantrone (MTO). Changes in particle size 
and zeta potential confirmed the existence of a coating layer on the surface of liposomes. The 
in vitro release of adsorbed CH from the liposomes was significantly slower than CH solution, 
indicating the stable interaction between CH and liposomes. The physical stability of the 
CH-coated liposomes was evaluated by measuring the change in particle size before and after 
freeze-drying and rehydration. The smallest change was observed when saturated adsorption 
of CH occurred (0.3%). The sustained release in vitro of MTO from CH-coated liposomes 
confirmed  the  increased  stability  of  liposomes.  Systemic  circulation  of  CH-coated  MTO 
liposomes was examined. The 0.3% CH-coated liposomes showed the longest circulation 
time. It could be concluded that the prolonged retention time of the liposomes was closely 
related with CH coating and its stability effect.
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Introduction
Liposomes are promising drug carriers because of their increased therapeutic efficacy 
and decreased toxicity compared with the drug prototype. Liposomes for anti-tumor 
drugs can passively accumulate in tumor tissues as a result of the enhanced permeability 
of tumor vasculature, thereby limiting drug distribution to normal tissues, which also 
helps decrease drug toxicity.1,2 However, the stability problem of liposomes in vitro 
and in vivo limits their application and development as liposomes tend to degrade or 
aggregate and fuse, which leads to the leakage of entrapped drug during storage3 and 
rapid clearance from the circulation system after intravenous injection.4 Many studies 
have found that, among all the factors affecting the stability of liposomes, surface 
characteristics of the carriers, such as hydrophobicity,4−6 charge,7,8 and fluidity,9 are 
of great importance. The mechanisms explaining their effect are associated with the 
inter-molecular interaction and the interaction with various plasma components.10 
Therefore, the simple surface modification of the carriers using polymers with specific 
properties may be an easy approach to modulating their in vitro and in vivo stability.
Polymer coating is a promising way of modifying the surface characteristics 
of liposomes, which simply mixes a liposome suspension with a polymer solution 
without chemically linking the polymers to the lipid molecules.11 By coating the 
liposomes with polymers, the stability of liposomes can be improved during storage 
due to the long-range mutual repulsion between adjacent bilayers. It has been reported 
that a variety of polymers have been incorporated into the modification of liposomes,  International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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including natural components such as polysaccharides, or 
synthetic polymers such as polyethylene, polyvinyl alcohol, 
or polyacrylamide,11−13 among which CH, a positively 
charged polysaccharide, is one with a promising future 
in the pharmaceutical and medical fields. CH ((1→4)-
2-amino-2deoxy-β-D-glucan), a deacetylated derivative of 
chitin, is an abundant and natural carbohydrate polymer. CH 
is regarded as nontoxic, biocompatible, biodegradable,14 and is 
widely used as a useful excipient in various drug delivery sys-
tems. To date, CH has been mainly applied to coat liposomes 
as a mucoadhesive polymer, and as a permeation enhancer for 
non-invasive drug delivery due to its ability to open epithelial 
tight junctions to allow for an increase in paracellular transport 
of macromolecular drugs. Another major application for CH is 
to form complex with vaccines or plasmid DNA in non-viral 
gene therapy.15 Studies on CH-coated liposomes as anti-tumor 
drug carriers for injection use are rare. In addition, most 
papers focused only on the in vitro properties of CH-coated 
liposomes, with few dealing with the systemic evaluation of 
them. In this paper, we tried to give an overall investigation 
on the in vitro and in vivo stability of CH-coated liposomes.
In this study, MTO, a synthetic anthraquinone deriva-
tive, was chosen as a model drug. MTO has been exten-
sively used for the treatment of various cancers; however, 
the dose-  related cardiotoxicity and myelosuppression of 
anthraquinone drugs limit their clinical use to a large extent. 
In recent years, preparations of MTO liposomes have been 
developed in an effort to decrease its adverse effects.16 
Clinically, MTO is of special effectiveness in the treatment 
of acute myelogenous leukemia. Therefore, the CH-coated 
MTO-containing liposomes are expected to enhance storage 
stability and prolong systemic circulation.
The objectives of the present work were: first, to obtain 
and characterize liposomes coated with CH by measuring 
the particle size and the zeta potential and second, to give 
a thorough investigation of the effect of polymer coating 
on in vitro and in vivo behavior of the obtained CH-coated 
liposomes by evaluating the physical stability through 
freeze-drying followed by rehydration (FD-RH) and the 
systemic circulation of the liposomes. More specifically, 
for the first time, we evaluated the in vitro desorption of CH 
from the liposomes using CH solution as control, further 
clarifying the lasting protective effect of CH for liposomes 
after entering systemic circulation in vivo in rat.
Methods and materials
Soybean phospholipid was a kind gift from Evonik Degussa 
China Co., Ltd (Shanghai, China) (purity . 90%). Cholesterol 
was purchased from Huixing Biochemical Reagent Co., Ltd 
(Shanghai, China). CH (degree of deacetylation: 92%, 
  viscosity average molecular weight: 70,000 Da) was pro-
vided by Nantong Shuanglin Biochemical Co., Ltd. (Jiangsu, 
China). Mitoxantrone dihydrochloride (99.1%) was obtained 
from Sichuan Shenghe Pharmaceutical Co., Ltd. Methanol 
was of HPLC grade. Other reagents were of analytical grade. 
Water was deionized before use.
Preparation of liposomes  
and CH-coated liposomes
Liposomes containing MTO were prepared by an ammonium 
sulfate gradient loading procedure.17 Unloaded liposomes 
composed of lipids and cholesterol (5:1 in molar ratio) were 
prepared by thin film hydration followed by sonication. Briefly, 
200 mg of PC and 20 mg of cholesterol were dissolved in 
a small amount of a mixture solution of methanol and 
chloroform, and the solution was rotary evaporated at 37°C 
under reduced pressure to obtain a thin lipid film. The thin 
lipid film was dried in vacuum overnight to ensure complete 
removal of the solvent and hydration was carried out with 
10 mL of aqueous ammonium sulfate (0.3 M) using a vortex 
mixer. The resultant multilamellar liposomal suspension was 
sonicated at 4°C using a micro-tip probe sonicator, JY 92-II 
ultrasonic processor (Syklon, Zhejiang, China) to obtain 
small unilamellar liposomes. After sonication, the unloaded 
liposomes were dialyzed against normal saline to remove 
the extraliposomal ammonium sulfate. The drug-loading 
liposomes were prepared by incubating the solution of MTO 
(4 mg/mL) with the suspension of the unloaded liposomes 
at 37°C for 20 min.
For preparation of CH-coated liposomes, an appropriate 
amount of CH was dissolved in 1% v/v of acetic acid solution 
and diluted with sodium acetate buffer solution (pH 6.0) to 
various concentrations (0.1%, 0.3%, 0.6% and 1.2%, w/v). 
Then, liposome suspension was added dropwise to CH 
solution of equal volume. The mixed solution was incu-
bated at 10°C for 1 hour with continuous stirring. The final 
concentrations of the lipids and CH were half of the original 
solutions, and the final MTO concentration in the CH-coated 
liposomes was 0.5 mg/mL.
Characterization of CH-coated 
liposomes
Particle size and zeta potential of CH-coated liposomes were 
measured by a Zetasizer 3000 HS (Malvern Instruments, 
Malvern, UK). Samples for transmission electron micros-
copy (TEM) were prepared at room temperature by International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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  conventional negative staining using 0.3% phosphotungstic 
acid buffer (pH 6.0). Samples were viewed on a transmission 
electron microscope H 7650 (Hitachi High-Technologies, 
Tokyo, Japan).
Content and entrapment  
efficiency of drug
Concentration of MTO was determined by HPLC. The HPLC 
system (Shimadzu Corporation, Kyoto, Japan) consisted 
of a LC-10AT pump and a SPD-10A UV detector set at 
658 nm. The analyte was determined at room temperature 
on a 150 mm × 4.6 mm Diamonsil® C18 column (Dikma 
  Technologies, Beijing, China). The mobile phase consisted 
of methanol – ammonium acetate buffer solution (20 mM)   
(48:52 v/v). The ammonium acetate buffer solution was 
adjusted to pH 2.0 with sulfuric acid before mixed with 
methanol. The mobile phase was pumped through the system 
at a rate of 1 mL/min.
The total drug content of suspensions was determined 
by dissolving liposomes in appropriate amount of methanol 
containing 1% (v/v) 1 M HCl (acidified methanol) and 
measured by HPLC.
The entrapment efficiency of the liposomes was 
determined using a gel filtration method. Free drug was 
separated from encapsulated MTO over a Sephadex G-25 
(1.4 cm × 35 cm) column. MTO-loaded liposomal suspension 
(0.5 mL) was added to the column. The encapsulated drug 
was eluted with 5% glucose solution and then the free 
drug was eluted with normal saline. One milliliter of the 
liposome elute was diluted with acidified methanol for HPLC 
and the eluted free drug was injected into the HPLC system 
directly. The total drug content of the suspensions was also 
determined. The encapsulation efficiency (EE) was calculated 
using Eq. (1):
  EE (%) = AUCE/AUCT × 100  (1)
where AUCE and AUCT are the area under the elution 
profile curve of the encapsulated and total drug in the feed, 
respectively.18
Coating efficiency of CH
Aliquots of CH-coated liposome suspensions (0.4 mL) were 
centrifuged at 12,000 rpm for 5 min in an ultimate filtration 
tube (molecular weight cut 10,000). The non-adhered CH 
at the bottom of the tube was determined by a colorimetric 
method described by Gao et al with a slight modification.19 
A solution of Alizarin Red S was prepared in deionized water, 
at a concentration of 1.5 mg/mL. To prepare the standard 
curve, a stock solution of CH was prepared at a concentration 
of 1 mg/mL. Different volumes of the stock solution were 
transferred into volumetric flasks. Aliquots of the dye solution 
(0.8 mL) were added to each flask, after which the volume 
in each flask was filled to 10 mL with sodium acetate buffer 
solution at a pH of 5.0. The UV adsorption was detected at 
580 nm with an 8453 UV-Visible Spectrophotometer (Agilent 
Technologies, Santa Clara, CA, USA) within 2 hours.
In vitro desorption of CH  
from liposomes
The aim of the study was to investigate the desorption of CH 
from the surface of the liposomes. To protect the liposomes 
from deteriorating by the plasma components, CH should 
not be removed immediately on dilution after entering the 
systemic circulation. In this experiment, 0.3% CH solution 
was first diluted with sodium acetate buffer solution at pH 6.0 
to half of the original concentration and used as control and 
CH (0.3%)-coated liposomes without MTO were first pre-
pared according to the method described in “Preparation of 
liposomes and CH-coated liposomes.” Thereafter, 4 mL of 
the CH-coated liposomes or 4 mL of CH solution was respec-
tively placed in a cellulose membrane tubing (molecular 
weight cut-off was 10,000, membrane pore size 10 nm). Then 
the tubing was tightened and soaked in 40 mL of phosphate 
buffer solution (pH 7.4) as dissolution medium. The experi-
ments were carried out at 37°C for 8 hours in 3 replicates. At 
predetermined intervals, 0.5 mL of the dissolution medium 
was withdrawn and replaced with the same amount of pre-
warmed dissolution medium. The samples of the replicates 
were pipetted directly into disposable cuvettes and analyzed 
for CH content as described in “Coating efficiency of CH.”
Statistical analysis was performed using Student’s t-test 
with P , 0.05 as the minimal level of significance on the 
raw data of the release rate of CH solution and adsorbed CH 
from liposomes at each time point.
Physical stability studies
The liposomal suspension was subjected to FD-RH with water 
to assess the physical stability of the liposomes. One mL of 
liposomal suspension was preparatively frozen at −70°C 
and applied to the LGJ-10 Freeze-Dry Machine, (Songyuan 
Huaxing Technology Development Co., Ltd., Beijing, China) 
for 24 hours. The freeze-dried cake was rehydrated with 1 mL 
of distilled water containing equal amount of 1% acetic acid 
(for uncoated liposomes, with water) by vortex-mixing till 
the cake was optically clear. The particle size of the dispersed  International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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liposomes was measured with a Zetasizer 3000 HS (Malvern 
Instruments, Malvern, UK).
In vitro drug release
In vitro release of MTO from liposomal formulations was 
analyzed by membrane dialysis. Pre-experiments were 
carried out on the in vitro release of MTO from liposomes 
with or without CH coating in phosphate buffer solution 
(pH 7.4), and less than 5% of MTO was released up to 
48 hours from each preparation (data not shown). In this 
study, equal amount of fetal cattle serum (FCS) was added 
to the liposome to simulate the in vivo environment. Briefly, 
4 mL of CH-coated liposomes mixed with 4 mL of FCS was 
placed in the cellulose membrane tubing (molecular weight 
cut-off was 8,000–10,000). For uncoated liposomes, sodium 
acetate buffer solution (pH 6.0) was added to the liposomes 
to adjust the concentration. Meanwhile, MTO aqueous solu-
tion was treated in the same way and used as control. Then 
the tubing was tightened and soaked in 200 mL of PBS 7.4 
as dissolution medium. The experiments were carried out at 
37°C for 48 hours in 3 replicates. At predetermined inter-
vals, 5 mL of the dissolution medium was withdrawn and 
replaced with the same amount of pre-warmed dissolution 
medium. The samples of the replicates were pipetted directly 
into disposal cuvettes and analyzed by an 8453 UV-Visible 
Spectrophotometer (Agilent Technologies, Santa Clara, CA, 
USA) at 658 nm.
In vivo studies
Animals
Wistar rats (200–240 g, male), obtained from the animal 
center of China Pharmaceutical University (Nanjing, China), 
were maintained under uniform experimental conditions 
(temperature 25 ± 2°C; humidity 60 ± 5%, 12 hours dark/
light cycle) for 1 week prior to experiments. They were fed 
with standard laboratory chow. All rats were fasted overnight 
before the experiment while water was provided ad libitum. 
All animal treatments followed the recommendations of the 
Regulations for the Administration of Affairs Concerning 
Experimental Animals.
Drug administration and blood sampling
Four groups of 6 rats each were treated with the normal 
saline solution of MTO, uncoated liposomes and CH-coated 
liposomes (0.3% and 0.6%, w/v) at a single MTO dose of 
13 mg/m2 via femoral vein injection, respectively. At each 
time point (5, 15, and 30 minutes and 1, 2, 4, 6, and 8 hours), 
blood samples (0.3 mL) were collected by oculi chorioidea 
vein into pre-labeled chilled micro-tubes containing heparin 
as an anticoagulant. Immediately after collection, each blood 
sample was gently inverted several times to ensure complete 
mixing with the anticoagulant. The blood samples were cen-
trifuged for 10 minutes at 4000 × g to separate plasma, and 
the latter was transferred to cryotubes and stored at −20°C 
until analysis.
Sample preparation
Plasma containing MTO was extracted by previously reported 
protein precipitation with slight modification.20 One hun-
dred µL of plasma was mixed with 200 µL of extraction 
solution (methanol containing 0.5 M hydrochloric acid: 
acetonitrile (90:10, v:v)). After vigorous vortexing, the 
samples were centrifuged for 10 minutes at 12,000 × g. The 
supernatants were removed and 20 µL was injected into the 
HPLC column for analysis.
Data analysis
Plasma concentrations versus time data were analyzed by 
Kinetica 4.4 (Thermo Electron Corporation, Waltham, 
MA, USA). Parameters including AUC, MRT, and t1/2 were 
determined.
A one-way ANOVA analysis was performed with 
P , 0.05 as the minimal level of significance.
Results and discussion
Morphological shape
The morphological appearance of CH-coated liposomes and 
uncoated liposomes was visualized using TEM (Figure 1). It 
could be seen that both types of liposomes presented a spherical 
morphology, yet no significant morphological differences 
between liposomes with or without CH coating were observed. 
This is probably due to the strong adsorption between the 
polymer and the liposomal bilayer, resulting in a flat con-
figuration and making it difficult to observe the polymer at 
the liposome surface. The same situation has been reported 
by others.21,22
Particle size and zeta potential
The liposomes were coated with CH at various concentrations 
in the solution. The particle size of the liposomes is shown 
in Figure 2. For measuring the particle size, liposomes were 
diluted by 20-fold with water. The particle size of CH-coated 
liposomes increased with the increased concentration of 
polymer solution, suggesting the formation of coating layer 
on the surface of the liposomes, and an increase in the thick-
ness of the coating layer with the increase of the polymer International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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concentration. However, the size did not change much before 
and after coating, only 1.34-fold as large as the original size 
even at the highest concentration of CH (1.2%, w/v). The 
small change in particle size of liposomes is preferable for 
circulation, since larger particles tend to be removed from the 
blood by the cells of the mononuclear phagocyte system.23 
The presence of strong intra-molecular electrostatic interac-
tions is an explanation for the thin layer formed around the 
liposomes.24 After adsorption, the strong attraction between 
segments of the polyelectrolyte chains and oppositely charged 
groups on the surface forces them to come into close proxim-
ity, forming a thin layer around the surface.25
The uncoated liposome had a marked negative charge 
(−30.4 mv) which, after the incubation with CH at various 
concentrations (0.02%, 0.04%, 0.2%, 0.3%, 0.6%, and 1.2% 
w/v), was inverted to positive value. This inversion of the 
surface charge of the liposomes confirmed the presence of 
CH coating on the surface of the liposomes. Therefore, the 
main interaction between liposomes and CH was electrostatic 
attraction. The zeta potential reached a relatively constant 
value as the CH concentration increased to 0.3% (Figure 3), 
indicating the saturated adsorption of CH to liposomes.
Entrapment efficiency of MTO
The entrapment efficiency of MTO was 97.4% for uncoated 
liposomes. The addition of CH decreased the entrapment 
efficiency slightly (Figure 4), probably due to the interaction 
of CH with the apolar head groups on the surface of 
phospholipid bilayers. When the concentration of CH 
increased to 0.3%, no more leakage of MTO was observed. 
Since saturated adsorption has achieved (see “Particle size 
and zeta potential”) and the stable coating layer formed, the 
excess CH could only surround the outside of the liposomes 
and were not able to interfere with the bilayer. A similar 
phenomenon has been reported previously.26
Coating efficiency of CH
The maximum adsorption of CH to the liposomes was 
achieved at a polymer concentration of 0.3% (see “Particle 
size and zeta potential”). The coating efficiency at maximum 
adsorption was estimated by measuring the concentration 
of free CH after centrifugation. The coating efficiency at 
maximum adsorption is 82%, and when calculated on a 
weight basis, the weight ratio of CH to phospholipids is 
1/8.13 at a polymer concentration of 0.3%.
In vitro desorption of CH  
from liposomes
Figure 5 depicts the CH desorption profile from the liposomes 
using CH solution as control. Both adsorbed CH and CH solu-
tion released 30% of their total amount within the first 5 min. 
After that, the release rate of adsorbed CH from liposomes 
was significantly slower than that of CH solution (P , 0.05). 
Maximum release of CH was obtained both at 8 h with a 
release of 80% of adsorbed CH from liposomes in contrast 
to 100% of CH solution. CH combines with the phospholipid 
A)
B)
Figure  1  Transmission  electron  micrographs  of  A)  uncoated  liposomes  and 
B) CH-coated liposomes. Bar is 100 nm. International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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bilayers mainly through electrostatic interactions. In addition, 
CH’s hydrophobic side chains can also exert hydrophobic 
interaction with the phospholipid bilayers.27 Due to the effect 
of the two kinds of interactions, the release of adsorbed CH 
was mostly retarded over the period. Therefore, it is reason-
able that CH can still protect the liposomes after entering the 
systemic circulation, and won’t be easily removed through 
dilution. The initial rapid release of adsorbed CH in the first 
5 minutes was probably due to the free CH molecules exist-
ing in the preparation, as shown by 82% coating efficiency 
of CH (0.3%).
Physical stability of CH-coated  
liposomes
The physical stability of the liposomes was evaluated by 
measuring the change in particle size after perturbing the 
system by FD-RH. Figure 6 illustrates the ratios of particle 
size for CH-coated or uncoated liposomes to original   values 
after FD-RH. The higher values of particle size ratio for 
uncoated liposomes suggest aggregation and/or fusion of 
liposomal particles during FD-RH. When liposomes are 
cooled to a temperature where ice crystals form in the 
aqueous phase, the liposome particles are forced closer 
together, leading to the fusion of the particles.25 The addition 
of CH improved the stability of liposomes against severe 
physical stress (−70°C). As the CH’s concentration increased 
from 0% to 0.3%, the values of particle size ratio decreased 
from 20 to 3.5. Chitosan contains hydroxyl groups along 
its backbone which can form hydrogen bonds between the 
polymer and water molecules. A similar protective mecha-
nism for the aggregation and/or fusion of liposomes during 
freezing or dehydration as in the case of carbohydrates is 
expected for the polymer layer on the surface of liposomes.23 
In addition, the protective effect of CH was partially attrib-
uted to the increased steric repulsion between the particles.28 
Furthermore, after dehydration, CH formed the “wall mate-
rial” surrounding the liposomal particles in the powder by 
forming a puseudohydration phase through their interaction 
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Figure 2 The influence of CH concentration on the size of CH-coated liposomes (n = 3).
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with phospholipid head groups,25 further improving the 
stability of the particles.
As the concentration of CH further increased from 0.3% 
to 1.2%, the protective effect against the physical stress with 
FD-RH slightly decreased. The values of particle size ratio 
increased from 3.5 (0.3% CH) to 6.25 (1.2% CH). Since the 
liposomal membrane was fully covered with CH molecules, 
the adsorbed polymer is sufficiently strong to prevent 
particle–particle interaction by steric stabilization, and the 
excess CH would not help to further increase the stability 
of liposomes. On the contrary, the stability of liposomes 
would be slightly impaired. Laye et al29 have proposed the 
so-called saturation concentration (Csat), which is the mini-
mum concentration of polymer required to cover the oppo-
sitely charged particles, and an empirical model to calculate 
it via the change in zeta potential:25
 
ζζ ζζ () ()  exp 0 c
c
sats at
sat
=+ −
−3c 
 

 
where ζ(c) is the zeta potential of liposomes at a CH 
  concentration of c, and ζ0 and ζsat are the initial and satu-
ration liposomal charges, respectively. According to the 
equation, the calculated Csat was 0.28%, which well agreed 
with the result we obtained in the zeta potential measurement 
(0.3%). According to Laye’s explanation, addition of CH to 
liposomes below and above the saturation concentration can 
both lead to the destabilization of liposomal dispersions.29 At 
insufficient polymer concentrations, the anionic phospholipid 
molecules of liposomes may have been bound to the cationic 
CH molecules to form coacervates rather than the cationic CH 
molecules wrapping themselves around the surfaces of 
the liposome particles. At excess polymer concentrations, 
the exclusion of polymer molecules from a narrow region 
surrounding the particle surfaces generates an attractive 
force that is strong enough to overcome the inter-molecular 
repulsive forces and to bring the particles together, making 
the liposomes susceptible to depletion flocculation.25,29 The 
narrow region (ie, “depletion zone”) was formed due to the 
conformational entropy restrictions. The “zone” existed 
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Figure 4 The effect of CH concentration on the entrapment efficiency of MTO (n = 3).
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between the surface of chitosan-coated particles and the 
surface in contact with a solution of non-adsorbing polymer. 
The polymer concentration in the depletion zone is lower 
than that of the bulk solution, resulting in an attractive force 
between the particles, which is proportional to the osmotic 
pressure of the polymer in the bulk solution.30,31
In vitro drug release
In the in vitro release study, an aqueous solution of MTO was 
released rapidly and almost completed within 7 h. However, 
the uncoated and CH-coated liposomes (CH concentration 
0.3% and 0.6%) released 31.39%–54.10% of MTO within 
48 h of dialysis as shown in Figure 7. The encapsulation of 
MTO into liposomes significantly slowed its release indicat-
ing the depot effect of liposomes, especially the CH-coated 
liposomal formulations. The sustained release behavior of 
MTO from polymer-coated liposomes was attributed to the 
retarded effect of CH coating and the stabilization of coated 
liposomes in the serum. Besides, CH at a concentration of 
0.3% had a better protective effect over CH at a concentration 
of 0.6%, which was in excellent agreement with the result 
obtained in FD-RH stability studies (“Physical stability of 
CH-coated liposomes”).
Pharmacokinetics of the CH-coated 
liposomes after intravenous injection  
in rats
Figure 8 depicts the plasma level-time profiles of MTO saline 
solution, uncoated liposomes and CH-coated liposomes after 
intravenous injection in rats. CH at a concentration of 0.3% 
and 0.6% were used to study the polymer coating effect on 
the systemic circulation of the liposomes. A rapid decrease of 
the drug from the systemic circulation for MTO solution was 
observed within 15 minutes, followed by a relatively slower 
and steady decrease. After 2 hours, the plasma concentration 
decreased to around the detection limit (20 ng/mL). Encap-
sulation of MTO in the liposomes significantly increased 
the retention time and plasma concentration (P , 0.05). 
The area under the curve (AUC) for the uncoated liposomes 
was 7.35-fold of that for the MTO solution (calculated from 
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the data shown in Table 1). Comparing the pharmacokinetic 
profiles of the uncoated liposomes and CH-coated liposomes, 
an even higher retention time and plasma concentration 
were observed for the latter, confirming the effectiveness of 
the steric coating layer of CH formed on the liposomal surface 
for prolonging the retention time of the carriers.
However, as the concentration of CH increased from 0.3% to 
0.6%, the retention of the liposome did not increase   accordingly, 
on the contrary, a decrease of both AUC and MRT were 
observed. The AUC and MRT value for CH-coated   liposomes 
at a concentration of 0.3% was 1.60-fold and 1.30-fold of that 
for CH at a concentration of 0.6%, respectively (calculated 
from the data shown in Table 1). This is in agreement with the 
result in physical stability and in vitro release studies, the excess 
CH leading to the decreased protective effect for liposomes, 
which means the dominant mechanism of prolonged retention 
of MTO in CH-coated liposomes is to stabilize the lipid bilayer 
membranes after entering the systemic circulation.
Conclusion
CH formed a hydrophilic layer on the surface of liposomes 
by a simple method of mixing a liposomal suspension with 
a polymer solution followed by incubation, resulting in 
particle size increment and positive zeta potential. The 
effectiveness of CH coating was confirmed by a sustained 
release of adsorbed CH from the liposomes compared 
with the CH solution. The enhancing physical stability 
of the resultant CH-coated liposomes was observed by 
FD-RH. The presence of free excess CH would decrease 
the stability of the liposomes. By comparing the circulat-
ing profiles of various liposomes with different coating 
amounts of CH, it was concluded that both the steric 
property of the coating layer and stabilization of the lipid 
bilayer membranes can affect the systemic circulation of 
the liposomes.
Polymer coating is an easy and flexible way to alter the 
surface properties of the liposomes, and CH, one of the 
most promising coating materials, is expected to be fully 
examined.
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Figure 8 Semi-log plasma concentration-time profiles in rats after intravenous administration of MTO solution (■), uncoated liposomes (◆), CH-coated liposomes (0.6%) 
(▲), and CH-coated liposomes (0.3%) (●) (n = 6).
Table 1 Mean pharmacokinetic parameters of MTO after intravenous administration of MTO solution, uncoated liposomes, CH (0.3%) 
and CH (0.6%)-coated liposomes
Parameters Solution Uncoated liposomes CH-coated liposomes  
(0.6%)
CH-coated liposomes   
(0.3%)
AUC (µg*mL−1* min) 162.33 ± 12.10 1193.50 ± 143.27* 1709.09 ± 203.53*,# 2738.16 ± 17.86*,#,
MRT (min) 18.73 ± 0.52 35.67 ± 4.76* 47.74 ± 0.96*,# 62.10 ± 2.15*,#,
t1/2 (min) 19.33 ± 1.23 35.07 ± 5.25* 46.73 ± 2.84*,# 50.22 ± 1.04*,#
Notes: Each value is the mean ± standard deviation, n = 6. *P , 0.05, compared with MTO solution; #P , 0.05, compared with uncoated liposomes; P , 0.05, compared 
with CH-coated liposomes (0.6%).International Journal of Nanomedicine
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